Výsledky vyhledávání - "William S. Velasquez"

Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501

Autor: C. Harris Spiridonidis, Keith S. Lanier, Danika Lew, Shaker R. Dakhil, Richard I. Fisher, Thomas M. Grogan, Robert A. Chapman, Stanley P. Balcerzak, William S. Velasquez, Thomas P. Miller

Publikováno v: Journal of Clinical Oncology. 21:1996-2003

Purpose: To determine the efficacy of combination fludarabine and mitoxantrone (FN) in untreated stages III and IV low-grade lymphoma. The major end point was to estimate progression-free survival (PFS) in all eligible patients. Patients and Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1a319cca2cd95d352c3fe3129789313
https://doi.org/10.1200/jco.2003.09.047

Zobrazit plný text záznamu

Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy

Autor: Douglas Adkins, Paul J. Petruska, R Niemeyer, Frank R. Dunphy, William S. Velasquez, W McIntyre, N Kronmueller, Gary Spitzer, M Mathews, Bowers C

Publikováno v: Bone Marrow Transplantation. 20:921-930

Fifty patients with either lymphoid or selected solid tumor malignancies were apheresed an identical number of times for PBSC collection after being randomized to receive either G-CSF 10 microg/kg/day alone (arm I), or G-CSF at the same dose with GM-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34472ee3e7a8420df7bfebc637b0ba2
https://doi.org/10.1038/sj.bmt.1700999

Zobrazit plný text záznamu

Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts

Autor: William S. Velasquez, Frank R. Dunphy, Paul J. Petruska, Gary Spitzer, Marilyn F. M. Johnston, Douglas Adkins

Publikováno v: Transfusion. 37:737-748

Background Granulocyte-colony-stimulating factor (G-CSF) is a safe and effective agent for mobilization of neutrophils in normal donors, consistently resulting in cell yields per leukapheresis (LA) procedure that are superior to those with other agen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507a6182a9d89ba8aeeb8e8a7ef6a087
https://doi.org/10.1046/j.1537-2995.1997.37797369451.x

Zobrazit plný text záznamu

Multiple Myeloma with Monoclonal Surface Immunoglobulin Expression

Autor: Cherie H. Dunphy, William S. Velasquez, Lorenzo M. Galindo

Publikováno v: Acta Cytologica. 40:358-362

BACKGROUND: Plasma cells from patients with multiple myeloma have been found to express the immunophenotype of normal plasma cells without surface immunoglobulin expression. CASE: A case occurred of multiple myeloma with monoclonal surface immunoglob

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::809ddc25fe5beb75e83d35aa9b0fb71b
https://doi.org/10.1159/000333768

Zobrazit plný text záznamu

Acute myelofibrosis terminating in acute lymphoblastic leukemia: Case report and review of the literature

Autor: Cherie H. Dunphy, Oscar Saravia, Sarah Kitchen, William S. Velasquez

Publikováno v: American Journal of Hematology. 51:85-89

Acute myelofibrosis (AMF), as defined by an acute panmyelopathy associated with marked megakaryocytic hyperplasia and marrow fibrosis, appears to be a stem cell disorder. Even though it is most difficult to distinguish from various myeloproliferative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::03d36c139137f0c9d9d5a8b995288224
https://doi.org/10.1002/(sici)1096-8652(199601)51:1<85::aid-ajh14>3.0.co

Zobrazit plný text záznamu

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Autor: F. Swan, William S. Velasquez, Andreas H. Sarris, Anas Younes, Susan L. Tucker, Herbert A. Fritsche, Maria Alma Rodriguez, Fernando Cabanillas, Fredrick B. Hagemeister, Jorge E. Romaguera, John R. Redman, Samer Suki, Peter McLaughlin

Publikováno v: Leukemia & Lymphoma. 18:87-92

We have previously proposed a staging system for large cell lymphoma using the two serum markers beta-2-microglobulin (B2M) and lactate dehydrogenase (LDH). We recently tested this model in a different cohort of patients with large cell lymphoma and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bc5d0a550166519393d33652b78002
https://doi.org/10.3109/10428199509064927

Zobrazit plný text záznamu

Translocation (15;17) and trisomy 21 in the microgranular variant of acute promyelocytic leukemia

Autor: Derrick W. Spell, Dennie V. Jones, William S. Velasquez, Gopalrao V.N. Velagaleti

Publikováno v: Cancer Genetics and Cytogenetics. 132:74-76

Cytogenetic abnormalities in acute myelogenous leukemia have been identified as one of the most important prognostic factors. Favorable chromosomal changes such as inv(16), t(8;21), and t(15;17) are associated with higher rates of complete remission

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2772e1ae96594d3e94c9e71ce6aa98b3
https://doi.org/10.1016/s0165-4608(01)00531-3

Zobrazit plný text záznamu

Autologous bone marrow transplantation in solid tumors

Autor: Gary Spitzer, William S. Velasquez, V. Spencer, Frank Dunphy

Publikováno v: Current Opinion in Oncology. 4:272-278

Recent studies in autologous bone marrow or peripheral blood transplantation in solid tumors are discussed. The toxicity and activity of high-dose cisplatin or carboplatin combined with etoposide and other drugs are described. The results of trials i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beef4259d1b628f03e5a355fb06ee58b
https://doi.org/10.1097/00001622-199204000-00006

Zobrazit plný text záznamu

Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial

Autor: Fernando Coutinho, Ana Rita Manhani, William S. Velasquez, Auro del Giglio

Publikováno v: Acta haematologica. 112(3)

We designed a phase I trial to assess the feasibility of the combination of topotecan, Ara-C, cisplatin and solumedrol (TOPOSHAP) in patients with relapsed or primary refractory lymphomas. We included 9 patients with mesurable non-Hodgkin’s (n = 8)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93d7b91c3658e6babfb524ae59f1923a
https://pubmed.ncbi.nlm.nih.gov/15345892

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání